Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.
暂无分享,去创建一个
Jose Belderbos | Mischa Hoogeman | M. Hoogeman | J. Lebesque | J. Belderbos | M. Rossi | W. Heemsbergen | K. Pengel | Maddalena Rossi | Wilma Heemsbergen | Joos Lebesque | Kenneth Pengel
[1] S. Kudoh,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] José Belderbos,et al. Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis , 2003 .
[3] Mischa S. Hoogeman,et al. The design and implementation of a multi-center volumetric and dosimetric database , 2000 .
[4] P. Maguire,et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. , 1999, International journal of radiation oncology, biology, physics.
[5] T. Bortfeld,et al. The use of computers in radiation therapy : XIIIth International Conference Heidelberg, Germany, May 22-25, 2000 , 2000 .
[6] P Baas,et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Joos V Lebesque,et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.
[8] Icru. Prescribing, recording, and reporting photon beam therapy , 1993 .
[9] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] C. Burman,et al. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.
[11] M. Satouchi,et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[12] R. Komaki,et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. , 1998, International journal of radiation oncology, biology, physics.
[13] P. van Luijk,et al. Estimation of parameters of dose-volume models and their confidence limits. , 2003, Physics in medicine and biology.
[14] H. Bartelink,et al. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer. , 2000, European journal of cancer.
[15] M. V. van Herk,et al. Quantification of local rectal wall displacements by virtual rectum unfolding. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] J. Lyman. Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.
[17] W. Curran,et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. , 2001, Chest.
[18] H. Fukuda,et al. European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas Blood 2008; 112(5):1600-9 , 2022 .
[19] H. Choy,et al. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. , 1999, Seminars in radiation oncology.
[20] Issam El-Naqa,et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. , 2004, International journal of radiation oncology, biology, physics.
[21] R Mohan,et al. Clinically relevant optimization of 3-D conformal treatments. , 1992, Medical physics.
[22] L. Boersma,et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] J. Lebesque,et al. The simultaneous boost technique: the concept of relative normalized total dose. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] Jeffrey D Bradley,et al. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[25] W. Curran,et al. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. , 2000, International journal of radiation oncology, biology, physics.
[26] M. Socinski,et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. , 2002, International journal of radiation oncology, biology, physics.
[27] J. Lebesque,et al. A treatment planning method to correct dose distributions distorted by setup verification fields. , 2000, International journal of radiation oncology, biology, physics.
[28] Target dose inhomogeneity and the location of recurrence , 2002 .
[29] A Ottolenghi,et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. , 2000, International journal of radiation oncology, biology, physics.